Biotech deal value hits $78B in H1 2026 but buyer capacity is shrinking, slowing future M&A pace.
Biotech mergers and acquisitions reached $78 billion in the first half of 2026, surpassing the entire 2025 total of $42 billion, driven by several large deals over $5 billion. Despite strong structural drivers like patent expirations and cash reserve...
